Rock Springs Capital Management LP Aadi Bioscience, Inc. Transaction History

Rock Springs Capital Management LP

  • $2.94 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$16.65 - $24.97 $8.97 Million - $13.5 Million
-538,835 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$19.32 - $29.02 $4.36 Million - $6.55 Million
-225,866 Reduced 29.54%
538,835 $13 Million
Q3 2021

Nov 15, 2021
BUY
$25.52 - $41.85 $19.5 Million - $32 Million
764,701 New
764,701 $22.5 Million

Others Institutions Holding AADI

# of Institutions
55
Shares Held
12.6M
Call Options Held
23.8K
Put Options Held
0
View Full List

About Aadi Bioscience, Inc.

AADI Quotes by TradingView
  • Ticker AADI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,016,800
  • Market Cap $71.2M
  • Description
  • Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, ...
More about AADI
Track This Portfolio

Track Rock Springs Capital Management LP Portfolio

Follow Rock Springs Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Springs Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email